「japan」の検索結果
86件：76～80件目を表示
-
tical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharmaceutical Co., Ltd. ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406.pdf -
tical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharmaceutical Co., Ltd. ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
Product Development Policy | Research & Development | SENJU Pharmaceutica
Satisfaction with treatment" and "Satisfaction with drugs" for various eye diseases (Japan)] This was based on an Internet survey of 260 ophthalmologists conducted by our company in 202...
http://www.senju.co.jp/english/rd/policy/ -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Completed jRCT2031250103 Dry Eye Disease 3 SJP-0132 China Completed NCT06717152 Healthy Volunt...
https://www.senju.co.jp/english/rd/trial.html -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Completed jRCT2031250103 Dry Eye Disease 3 SJP-0132 China Completed NCT06717152 Healthy Volunt...
http://www.senju.co.jp/english/rd/trial.html